INS and Alzheimer disease: Whereas this idea stemmed from clinical observations suggestive of that AD is a metabolic disease in which brain cannot efficiently utilize glucose, experimental observations of impairments of insulin, as well as insulin growth factors (IGF-1, IGF-2) signaling following icv STZ in rat pups [79, 80] were interpreted as providing the strongest evidence favoring this concept.